Filing Details

Accession Number:
0001415889-24-002870
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-06 21:41:25
Reporting Period:
2024-02-02
Accepted Time:
2024-02-06 21:41:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
855654 Immunogen Inc. IMGN Pharmaceutical Preparations (2834) 042726691
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1838777 Renee Lentini C/O Immunogen, Inc.
830 Winter Street
Waltham MA 02451
Vp & Prin Acctg Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-02 8,435 $0.00 17,354 No 4 M Direct
Common Stock Disposition 2024-02-05 2,631 $29.30 14,723 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2024-02-02 8,435 $0.00 8,435 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
16,870 No 4 M Direct
Footnotes
  1. Effected pursuant to a trading plan adopted on June 6, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  2. Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
  3. The RSUs were granted on 2/3/2023 and vest over a three-year period, with 33 1/3% of the RSUs vesting on each of the first three anniversaries of the date of grant, subject to continued service through each vesting date.